Fresenius Kabi Issues Voluntary Nationwide Recall of 13 Lots of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter in Reserve Samples
Fresenius Kabi USA, LLC is voluntarily recalling 13 lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL, 1 mL fill in a 2 mL amber vial and Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL fill in a 2 mL amber vial to the user level due to the presence of particulate matter (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 20, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates
Hikma Pharmaceuticals PLC (Hikma, Group), today announces that its subsidiary Hikma Pharmaceuticals USA Inc. (formerly known as West-Ward Pharmaceuticals Corp.; “Hikma”) is voluntarily extending its previously-announced recall of certain lots (listed below) of Ketorolac Tromethamine Injection USP 30 (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 5, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Zyla Life Sciences Announces Management Changes
WAYNE, Pa., Oct. 23, 2019 -- (Healthcare Sales & Marketing Network) -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company, today announced that Robert Radie, has resigned as president, chief executive officer and... Biopharmaceuticals, Personnel Zyla Life Sciences, SPRIX, ketorolac tromethamine, ZORVOLEX, VIVLODEX, meloxicam (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 23, 2019 Category: Pharmaceuticals Source Type: news

Zyla Life Sciences Appoints Dr. H. Jeffrey Wilkins as Chief Medical Officer
WAYNE, Pa., June 12, 2019 -- (Healthcare Sales & Marketing Network) -- Zyla Life Sciences (OTCQX:ZCOR) ("Zyla"), a growing commercial-stage life sciences company, announced the appointment of H. Jeffrey Wilkins, M.D. as senior vice president and... Biopharmaceuticals, Personnel Zyla Life Sciences, SPRIX, ketorolac tromethamine, ZORVOLEX, VIVLODEX, meloxicam (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2019 Category: Pharmaceuticals Source Type: news

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL). This product was manufactured by Zydus (Cadila Healthcare Limited) and distributed by Sagent Pharmaceuticals, Inc. Sagent has initiated this volun (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 3, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ketorolac Tromethamine Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - June 5, 2018 Category: Drugs & Pharmacology Source Type: news

Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
WAYNE, Pa., May 29, 2018 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for ... Biopharmaceuticals, Reimbursement Egalet Corp, SPRIX , ketorolac tromethamine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 13, 2018 Category: Drugs & Pharmacology Source Type: news

Acuvail (Ketorolac Tromethamine Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Acular LS (Ketorolac Tromethamine Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Acular (Ketorolac Tromethamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Toradol (Ketorolac Tromethamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Sprix (Ketorolac Tromethamine Nasal Spray) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 9, 2016 Category: Drugs & Pharmacology Source Type: news

Ketorolac Tromethamine Injection (Updated - Resolved)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 23, 2016 Category: Drugs & Pharmacology Source Type: news

Ketorolac Tromethamine Injection by Hospira: Recall - Particulate in Glass Vials
Administration of particulates has the potential for localized inflammation, allergic reaction, granuloma formation, microembolic effects, or delay of therapy. (Source: FDA MedWatch)
Source: FDA MedWatch - February 11, 2015 Category: American Health Source Type: news

Ketorolac Tromethamine Injection by Sagent Pharmaceuticals Recalled:...
On October 6, the FDA announced that three lots of Ketorolac Tromethamine Injection, USP, 30mg/mL single-dose vials, distributed by Sagent, are recalled due to incorrect labeling. In light of this...(PRWeb October 09, 2014)Read the full story at http://www.prweb.com/releases/2014/10/prweb12235068.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 9, 2014 Category: Pharmaceuticals Source Type: news

Ketorolac Tromethamine Injection, USP, 30mg/ml by Sagent Pharmaceuticals: Recall - Incorrect Labeling
The labeled expiration date is longer than the known stability of the product. (Source: FDA MedWatch)
Source: FDA MedWatch - October 6, 2014 Category: American Health Source Type: news